Amble’s advertised monthly price is not enough to build a reliable treatment budget. Its homepage says plans start at $99 per month, but that block does not identify a medicine or the conditions needed to obtain that rate. More specific GLP-1 pages show higher figures, multiple plan durations and a first-month promotion. One page even gives two different monthly prices for a six-month plan. The useful question is therefore not simply what Amble costs, but what a particular written offer purchases.
This review examines Amble’s documented prices, included services and payment boundaries using sources consulted October 19, 2026. Amble presents itself as a technology and administrative platform connecting patients with outside clinicians and pharmacies, including for compounded GLP-1 treatment. It is not itself the dispensing pharmacy or medical facility. The documents describe meaningful service features, but leave important details unresolved, including some formulation-to-price matches, collection schedules and renewal amounts. Those gaps matter most when a discounted plan carries a longer commitment.
At a glance
- The homepage starting price is not a confirmed GLP-1 quote
- Amble advertises plans starting at $99 per month without identifying the treatment or qualifying duration in that block.Sources: [8]
- The six-month GLP-1 price conflicts
- Two tables on the GLP-1 page list the six-month plan at $135 and $145 per month; both list three months at $160 and one month at $179.Sources: [7]
- One promotion is explicitly introductory
- A promotional page advertises a one-month supply for $129 versus $179, with $50 off the first month automatically applied at checkout.Sources: [10]
- The pharmacy handoff limits refunds
- The terms allow a full refund before an order is sent to the pharmacy, but exclude cancellation and refunds afterward for every month covered by that order.Sources: [9]
- Renewal cancellation requires advance notice
- Cancellation requests must be received at least 15 days before the next billing date to avoid another charge.Sources: [9]
Start with the specific offer, not the homepage headline
Amble’s homepage combines a starting price of $99 per month with statements that insurance is not required and there are no membership fees or hidden costs. That is an entry-level advertising statement, not a documented price for a particular GLP-1 formulation. The supplied block does not connect $99 to an active ingredient, route, supply quantity or plan duration. It should not substitute for a product-specific quote, especially when the dedicated treatment pages show different prices.
The GLP-1 page provides more detail but introduces a discrepancy. One table lists $135 per month for six months, $160 for three months and $179 for one month. Another lists $135 for 12 months, $145 for six months, $160 for three months and $179 for one month. The six-month figures cannot both describe the same unchanged offer. The documents do not resolve which applies, so neither should be presented as the definitive six-month rate.
A separate promotional page advertises $129 against $179 for a one-month supply, explicitly describing $50 off the first month, automatically applied at checkout. That supports an introductory offer, not an indefinitely recurring $129 price. Before paying, ask for the first charge and the subsequent charge in writing. Our guide to reading introductory offers and renewal prices explains why a crossed-out comparison price is not, by itself, a complete renewal schedule.
| Advertised offer | Published amount | Important qualification |
|---|---|---|
| Homepage starting price | Starting at $99 per month | Treatment and qualifying duration are not identified in the block. |
| GLP-1 one-month plan | $179 per month | The generic label does not establish the exact formulation. |
| GLP-1 six-month plan | $135 or $145 per month | Two tables on the same page conflict. |
| GLP-1 introductory promotion | $129 for a one-month supply versus $179 | $50 discount applies only to the first month. |
| Compounded GLP-1 + GIP & NAD+ Injection | $250 for a one-month supply | The page does not resolve whether this is a mixture or separate products. |
Different treatment labels need different price questions
Amble’s GLP-1 + GIP page lists monthly costs of $235 for a six-month billing cycle, $255 for three months and $329 for one month. The same block advertises $50 off the first month, automatically applied at checkout. It does not clearly explain whether the displayed monthly figures already incorporate that discount. Subtracting another $50 would therefore be an assumption, not a verified quote. Ask which figure will actually be collected and what happens after the introductory period.
Another page advertises “Compounded GLP-1 + GIP & NAD+ Injection” at $250 for a one-month supply, alongside “same price, every dose,” no required insurance and free shipping. That named offer should remain separate from the generic GLP-1 + GIP table. The documents do not establish whether NAD+ is mixed into one preparation or provided separately. Nor do they establish that every generic GLP-1 price corresponds to the same active ingredient, formulation or presentation.
The safety information discusses compounded semaglutide and compounded tirzepatide as possible prescriptions following clinical evaluation. Amble also says it facilitates FDA-approved and compounded medication fulfillment through partner pharmacies, but that broad statement does not verify availability or pricing for every branded medicine mentioned elsewhere. For comparison shopping, request the exact medicine, ingredients, route, presentation and supplied quantity alongside the price. A category name alone does not make two offers equivalent purchases.
A monthly equivalent does not settle the payment schedule
The longer-plan prices are presented as monthly amounts, but the supplied pricing blocks do not establish whether the entire selected duration is collected upfront or through installments. They also do not settle the final charge at renewal. A six-month label cannot answer those questions on its own. Before authorizing payment, distinguish the advertised monthly equivalent from the amount charged today, the next billing date and the duration of the financial obligation.
That distinction matters because Amble’s terms describe discounted extended memberships as a firm commitment to the full selected program duration. The homepage’s statement that there are no membership fees does not erase that contractual language: a separate membership fee and a commitment to a treatment program are different issues. The supplied documents do not provide enough detail to characterize every plan as either prepaid or freely cancelable month to month. Our explanation of monthly and prepaid billing structures helps separate those concepts.
Dispensing can occur in one- or three-month increments, depending on the prescription, pharmacy availability, dosage requirements and applicable regulations. That does not establish how much medicine every advertised package contains or when it will arrive. Price stability is also qualified: Amble says prices may change because of supply or market conditions, and a “same price at every dose” promotion expires within 24 hours of a price update. Treat the slogan as conditional, not a documented permanent price lock.
What the advertised bundle includes—and where another bill may appear
Amble describes its standard pricing as flat-rate without insurance, including medication, supplies and shipping, with ongoing clinical follow-up included across plans. Its GLP-1 page also advertises secure messaging and scheduled physician check-ins. These inclusions make the offer more informative than a medication-only price, but they do not answer every budget question. The supplied documents do not specify concrete laboratory requirements or establish whether any required testing would be included, separately billed or arranged elsewhere.
An optional anti-nausea medication is advertised for eligible patients, but its price is not supplied here. That add-on should not automatically be treated as part of the base package. A separate exception appears in the terms for prescriptions sent to a patient-selected outside pharmacy: the patient is responsible for obtaining the medication and paying that pharmacy directly. The standard included-medication promise therefore should not be generalized to every fulfillment route. See our guide to separate program and pharmacy bills.
Payment-method conditions also deserve attention. Although Amble advertises HSA/FSA eligibility, its FAQ says those cards are accepted for plans lasting three months or longer, and itemized receipts are available for submission to a benefits provider. That does not establish reimbursement eligibility for an individual account. Similarly, “no insurance required” does not confirm whether Amble accepts or bills a particular insurer. The supplied evidence supports a self-pay offer, not a verified insurance benefit.
Cancellation has two separate financial boundaries
Amble’s clearest refund boundary is the pharmacy handoff. Before an order is sent to the pharmacy, its terms allow cancellation with a full refund and no cancellation fee. Once an order has been sent for preparation, the terms say it cannot be canceled or refunded, including every month of supply covered by that order. That boundary is not delivery, first use or the end of the first month. A multi-month order can therefore have consequences beyond the next shipment.
Stopping a future renewal is a separate process. The terms allow requests by email, with identifying and subscription information, or through the patient dashboard. To ensure another charge is avoided, the request must be received at least 15 days before the next billing date. Later requests may be processed for the following billing cycle. A dashboard cancellation request should not be mistaken for reversal of an order already sent to the pharmacy.
Before enrollment, ask when the initial order is transmitted, which months it covers and when the next billing date falls. Save the applicable cancellation terms and request confirmation when a cancellation is submitted. These are administrative preparations, not guarantees that a dispute will be resolved in a particular way. Our guide to cancellation and refund boundaries explains the distinction. The supplied terms also omit a central section, so this documentary contract review is necessarily partial.
What happens between intake and a prescribing decision
Amble advertises a free, fully online assessment covering health history, lifestyle and goals. Its intake also asks about current medications. According to the provider, a state-licensed physician reviews the questionnaire, completes a clinical evaluation and conducts a live phone or video consultation when required. The GLP-1 page specifically lists New Mexico, Kansas, West Virginia, Louisiana and Mississippi as requiring a brief audio or video visit; it says an online health review may suffice in most other states.
The platform says the professionals available through it are physicians licensed across all 50 states. These are provider statements, not independently verified licensing findings. Amble Health Inc. and its affiliates operate the website, while Amble describes its role as managed administrative and technology services rather than medical advice or prescription dispensing. The sample does not identify the medical practices responsible for individual patients. A prescribing decision remains at the clinician’s discretion; completing intake does not guarantee medication.
The terms restrict services to adults at least 18 or the age of majority in their jurisdiction, located in U.S. states where services are available. Although the FAQ advertises availability in all 50 states, it expressly adds that exclusions apply. Those exclusions are not resolved by treatment or location in the supplied material. Confirm availability for the specific product and current location before committing financially, rather than treating the nationwide advertising statement as unconditional access.
Pharmacy, delivery and follow-up responsibilities
Amble says prescribed GLP-1 medicines are dispensed through state-licensed U.S. pharmacies, and it distinguishes state-regulated 503A pharmacies from FDA-registered 503B outsourcing facilities. Those descriptions do not identify the pharmacy preparing an individual order or independently establish its credentials. The terms name Bask Health, Inc. in connection with third-party prescription-fulfillment services; that is not confirmation that Bask is the dispensing or compounding pharmacy. Request the actual pharmacy’s name and contact information for the proposed prescription.
The advertised fulfillment process includes cold shipping at no additional cost, discreet packaging and delivery to the address specified by the patient, with usage instructions. No guaranteed clinical review, preparation, transit or arrival timeline is established in the supplied documents. Free shipping is an included delivery charge, not free treatment or a delivery-speed guarantee. The terms also warn that network prescriptions may not use child-resistant packaging, a practical detail worth resolving before an order is dispatched.
For ongoing support, Amble advertises secure 24/7 messaging, scheduled physician check-ins, nutrition tips and meal ideas. Its terms qualify that communications may not occur in real time and that the site does not provide urgent or emergency services. Messaging availability therefore does not establish an immediate clinician response. Ask how to reach the prescribing practice and dispensing pharmacy separately, who handles shipment problems and what follow-up is scheduled rather than available only upon request.
Price comparisons cannot establish clinical equivalence
The FDA states that compounded preparations are not FDA approved and do not undergo its premarket review for safety, effectiveness and quality. Nonapproval alone does not demonstrate clinical inequivalence, and it does not establish that a particular provider is good or bad. FDA recommends compounded drugs when an individual’s medical needs cannot be met by an approved drug, with a prescription and a state-licensed pharmacy. That makes the clinical reason for the proposed preparation an important consultation question.
FDA has received reports of compounded-medication measurement or administration errors, some involving hospitalization. Instructions should be clarified with the prescriber or pharmacist rather than reconstructed from a price comparison or review. For injectable GLP-1 medication that arrives warm or inadequately refrigerated, FDA explicitly advises not using it and contacting the provider or dispensing pharmacy. Included cold shipping does not remove the need for a clear process to resolve a temperature concern.
NIDDK advises discussing benefits, side effects, other medicines, health conditions and costs with the treating clinician. Follow-up should address response and tolerability, not simply authorize another payment. Research on particular approved products does not establish outcomes for Amble, compounded versions or vitamin-containing combinations. When comparing offers, keep the documented financial terms separate from clinical judgments: a higher price does not prove better care, and a lower one does not establish that a formulation meets an individual’s needs.
Questions & answers
Is Amble’s $99 starting price a verified GLP-1 price?
Not from the supplied homepage block. It says plans start at $99 per month but does not identify the treatment or qualifying duration. Dedicated GLP-1 pages advertise other amounts, including $179 for a one-month plan and a $129 first-month promotion. Ask for a quote naming the exact prescription and payment schedule rather than using the homepage minimum as your expected charge.
Does a six-month Amble plan require full payment upfront?
The supplied pricing blocks do not establish the collection schedule. They show monthly amounts, while the terms describe a firm commitment for discounted extended memberships. Confirm the amount collected today, any installment schedule, the next billing date and the cancellation consequences. Also resolve the six-month GLP-1 price discrepancy: the same page lists both $135 and $145 per month.
What does Amble say its standard price includes?
Amble lists medication, supplies and shipping, plus ongoing clinical follow-up. It also advertises secure messaging and scheduled physician check-ins. The documents do not settle laboratory costs, and the optional anti-nausea medication has no documented price here. If a prescription goes to an outside pharmacy selected by the patient, the terms make the patient responsible for obtaining it and paying that pharmacy directly.
Can I cancel Amble and receive a refund?
The terms allow a full refund without a cancellation fee before an order is sent to the pharmacy. After that handoff, they exclude cancellation and refunds for all months covered by the order. Future renewals have a separate rule: cancellation must be received at least 15 days before the next billing date to avoid another charge. Stopping renewal does not automatically refund an existing order.
Can I use an HSA, FSA or insurance with Amble?
Amble’s FAQ says HSA and FSA cards are accepted for plans of three months or longer, and itemized receipts are available. That does not guarantee reimbursement under an individual benefits arrangement. Amble advertises pricing without required insurance, but the supplied documents do not establish whether it accepts or bills your insurer. Confirm payment acceptance and any benefit eligibility separately before purchasing.
Does Amble’s 24/7 messaging mean immediate physician access?
No immediate response is established. Amble advertises secure messaging available around the clock and scheduled physician check-ins, but the terms say communications may not be real time. They also exclude urgent and emergency services. Before enrolling, ask about expected response times, scheduled follow-up and separate contact routes for the prescribing practice and dispensing pharmacy; the supplied documents do not provide guaranteed response windows.
Our assessment
Amble documents a potentially convenient self-pay arrangement: online assessment, clinician review, medication and supplies, included shipping and ongoing support. Its pricing is less settled than the flat-rate message suggests. The conflicting six-month figures, incomplete formulation-to-price mapping and unclear collection schedules prevent a single dependable headline cost. The practical dividing line is whether Amble supplies a written, product-specific quote that resolves those issues before payment. That quote should identify the first and later charges, commitment duration, pharmacy, included services and cancellation dates. Longer-plan discounts also need to be weighed against the firm commitment and the loss of refund rights once an order reaches the pharmacy. The documentation supports considering Amble as a GLP-1 access platform, but not assuming a guaranteed prescription, a permanent advertised rate or uncomplicated early exit.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.
- FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
- NIDDK: prescription medications for overweight and obesity ↗
- Wilding et al. (2021): STEP 1 semaglutide trial ↗
- Jastreboff et al. (2022): SURMOUNT-1 tirzepatide trial ↗
- Amble — lp/shop glp 1 gip v2 ↗
- Amble — lp/glp 1 gip nad ↗
- Amble — glp 1 injections ↗
- Amble — official website ↗
- Found — terms of service ↗
- Amble — lp/shop glp 1 v3 ↗
- Found — faq ↗